Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:01 pm Purchase | 2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Armistice Capital, LLC | 9,134,817 9.990% | 9,134,817 (New Position) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 4,731,150 5.100% | -3,230,997 (-40.58%) | Filing History |
| 2025-02-12 4:05 pm Purchase | 2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Caligan Partners LP | 15,856,653 9.990% | 15,856,653 (New Position) | Filing History |
| 2024-12-09 6:22 pm Purchase | 2024-12-05 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 7,962,147 8.700% | 862,965 (+12.16%) | Filing History |
| 2024-11-26 4:15 pm Purchase | 2024-11-22 | 13D | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 52,504,049 49.900% | 37,114,568 (+241.17%) | Filing History |
| 2024-11-14 09:32 am Sale | 2024-09-30 | 13G | Verrica Pharmaceuticals Inc. VRCA | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -6,583,332 (Position Closed) | Filing History |
| 2024-02-14 4:47 pm Purchase | 2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 7,099,182 16.900% | 2,060,199 (+40.89%) | Filing History |
| 2024-02-14 09:10 am Purchase | 2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | AVORO CAPITAL ADVISORS LLC | 6,583,332 9.990% | 6,583,332 (New Position) | Filing History |
| 2023-02-14 2:37 pm Purchase | 2022-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 5,038,983 12.300% | 1,428,571 (+39.57%) | Filing History |
| 2022-07-15 4:15 pm Purchase | 2022-07-05 | 13D | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 15,389,481 37.400% | 4,761,904 (+44.81%) | Filing History |
| 2022-02-14 4:37 pm Purchase | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 10,627,577 38.600% | 789,830 (+8.03%) | Filing History |
| 2022-02-14 3:54 pm Purchase | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 3,610,412 13.100% | 200,000 (+5.86%) | Filing History |
| 2022-02-11 4:57 pm Unchanged | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-01-27 11:04 am Sale | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Davidson Matt | 560,731 2.040% | -884,272 (-61.20%) | Filing History |
| 2021-02-16 8:57 pm Purchase | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 3,410,412 13.200% | 3,410,412 (New Position) | Filing History |
| 2021-02-16 4:04 pm Purchase | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 9,837,747 38.000% | 194,500 (+2.02%) | Filing History |
| 2021-02-16 3:47 pm Sale | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 0 0.000% | -3,410,412 (Position Closed) | Filing History |
| 2021-01-25 5:13 pm Sale | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Davidson Matt | 1,445,003 5.600% | -1,028,157 (-41.57%) | Filing History |